abstract |
The present invention provides binding molecules specific for LIF and uses thereof, in particular, the present invention provides isolated antibodies or antigen-binding portions thereof that bind to LIF and inhibit LIF activity. The present invention also provides the use of the isolated antibodies or antigen-binding portions thereof of the present invention in the treatment of diseases. |